(Nasdaq:LEXX)(Nasdaq:LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms is pleased to announce that dosing has been completed for human pilot study #3 (the 'Study') ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback